Search research articles
Contact Us
Filters
Showing results (401-410 of 466) with videos related to
Page
of 47
Sort By:
Blood
|
January 15, 2016
Postibrutinib outcomes in patients with mantle cell lymphoma
Peter Martin, Kami Maddocks, John P Leonard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2016
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network
Eva Hoster, Andreas Rosenwald, Françoise Berger, et al.
Genes, Chromosomes & Cancer
|
November 3, 2019
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia
Paurnima Patil, Agata Cieslak, Stephan H Bernhart, et al.
Journal of Cancer Research and Clinical Oncology
|
January 18, 2025
Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
Volker Arndt, Daniela Doege, Stefan Fröhling, et al.
The Journal of Allergy and Clinical Immunology
|
February 21, 2017
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase
Xiao Liu, Tica Pichulik, Olaf-Oliver Wolz, et al.
Journal of Cancer Research and Clinical Oncology
|
October 14, 2022
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
Volker Arndt, Daniela Doege, Stefan Fröhling, et al.
Cancer Research
|
April 20, 2019
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma
Jennifer Hüllein, Mikołaj Słabicki, Maciej Rosolowski, et al.
Hemasphere
|
February 20, 2020
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)
Nadine Kutsch, Jasmin Bahlo, Sandra Robrecht, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 27, 2019
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia
Thomas J Kipps, Graeme Fraser, Steven E Coutre, et al.
Blood
|
January 13, 2026
The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia
Othman Al-Sawaf, Benjamin Nick Locher, Friederike Christen, et al.
Page
of 47
Search research articles
Search
Showing results (401-410 of 466) with videos related to
Sort By:
Page
of 47
Blood
|
January 15, 2016
Postibrutinib outcomes in patients with mantle cell lymphoma
Peter Martin, Kami Maddocks, John P Leonard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2016
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network
Eva Hoster, Andreas Rosenwald, Françoise Berger, et al.
Genes, Chromosomes & Cancer
|
November 3, 2019
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia
Paurnima Patil, Agata Cieslak, Stephan H Bernhart, et al.
Journal of Cancer Research and Clinical Oncology
|
January 18, 2025
Correction: Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
Volker Arndt, Daniela Doege, Stefan Fröhling, et al.
The Journal of Allergy and Clinical Immunology
|
February 21, 2017
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase
Xiao Liu, Tica Pichulik, Olaf-Oliver Wolz, et al.
Journal of Cancer Research and Clinical Oncology
|
October 14, 2022
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
Volker Arndt, Daniela Doege, Stefan Fröhling, et al.
Cancer Research
|
April 20, 2019
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma
Jennifer Hüllein, Mikołaj Słabicki, Maciej Rosolowski, et al.
Hemasphere
|
February 20, 2020
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)
Nadine Kutsch, Jasmin Bahlo, Sandra Robrecht, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 27, 2019
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia
Thomas J Kipps, Graeme Fraser, Steven E Coutre, et al.
Blood
|
January 13, 2026
The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia
Othman Al-Sawaf, Benjamin Nick Locher, Friederike Christen, et al.
Page
of 47